Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1501 AL 1515

Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?

Furgiuele A, Pereira FC, Martini S, Marino F, Cosentino M.

Clin Transl Immunology. 2023 Sep 29;12(10):e1469. doi: 10.1002/cti2.1469. eCollection 2023.

Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments

Scarpa E, Cascione M, Griego A, Pellegrino P, Moschetti G, De Matteis V.

Ibrain. 2023 Aug 14;9(3):298-315. doi: 10.1002/ibra.12126. eCollection 2023 Fall.

NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders

Zilberter Y, Tabuena DR, Zilberter M.

Prog Neurobiol. 2023 Dec;231:102539. doi: 10.1016/j.pneurobio.2023.102539. Epub 2023 Oct 12.

Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders

De Marchi F, Munitic I, Vidatic L, Papić E, Rački V, Nimac J, Jurak I, Novotni G, Rogelj B, Vuletic V, Liscic RM, Cannon JR, Buratti E, Mazzini L, Hecimovic S.

Biomedicines. 2023 Oct 14;11(10):2793. doi: 10.3390/biomedicines11102793.

Community-based neuropalliative care

Olvera CE, Levin ME, Fleisher JE.

Handb Clin Neurol. 2023;191:49-66. doi: 10.1016/B978-0-12-824535-4.00001-X.

Altered delay discounting in neurodegeneration: insight into the underlying mechanisms and perspectives for clinical applications

Godefroy V, Sezer I, Bouzigues A, Montembeault M, Koban L, Plassmann H, Migliaccio R.

Neurosci Biobehav Rev. 2023 Mar;146:105048. doi: 10.1016/j.neubiorev.2023.105048. Epub 2023 Jan 18.

Disease mechanisms as subtypes: Microbiome

Bonvegna S, Cilia R.

Handb Clin Neurol. 2023;193:107-131. doi: 10.1016/B978-0-323-85555-6.00006-0.

Connecting the Gut Microbiota and Neurodegenerative Diseases: the Role of Bile Acids

Wang S, Xu C, Liu H, Wei W, Zhou X, Qian H, Zhou L, Zhang H, Wu L, Zhu C, Yang Y, He L, Li K.

Mol Neurobiol. 2023 Aug;60(8):4618-4640. doi: 10.1007/s12035-023-03340-9. Epub 2023 May 1.

Apathy in Parkinson's Disease: Clinical Patterns and Neurobiological Basis

Béreau M, Van Waes V, Servant M, Magnin E, Tatu L, Anheim M.

Cells. 2023 Jun 10;12(12):1599. doi: 10.3390/cells12121599.

Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview

Alshial EE, Abdulghaney MI, Wadan AS, Abdellatif MA, Ramadan NE, Suleiman AM, Waheed N, Abdellatif M, Mohammed HS.

Life Sci. 2023 Dec 1;334:122257. doi: 10.1016/j.lfs.2023.122257. Epub 2023 Nov 8.

The Landscape of Monogenic Parkinson's Disease in Populations of Non-European Ancestry: A Narrative Review

Koros C, Bougea A, Simitsi AM, Papagiannakis N, Angelopoulou E, Pachi I, Antonelou R, Bozi M, Stamelou M, Stefanis L.

Genes (Basel). 2023 Nov 17;14(11):2097. doi: 10.3390/genes14112097.

Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease

Tapias V, González-Andrés P, Peña LF, Barbero A, Núñez L, Villalobos C.

Antioxidants (Basel). 2023 Jun 15;12(6):1282. doi: 10.3390/antiox12061282.

Impact of Safinamide on Patient-Reported Outcomes in Parkinson's Disease

Espinoza-Vinces C, Villino-Rodríguez R, Atorrasagasti-Villar A, Martí-Andrés G, Luquin MR.

Patient Relat Outcome Meas. 2023 Oct 10;14:285-295. doi: 10.2147/PROM.S369590. eCollection 2023.

An adverse outcome pathway for chemical-induced Parkinson's disease: Calcium is key

Meerman JJ, Legler J, Piersma AH, Westerink RHS, Heusinkveld HJ.

Neurotoxicology. 2023 Dec;99:226-243. doi: 10.1016/j.neuro.2023.11.001. Epub 2023 Nov 4.

Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders

Pagonabarraga J, Álamo C, Castellanos M, Díaz S, Manzano S.

Brain Sci. 2023 Feb 13;13(2):318. doi: 10.3390/brainsci13020318.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias